| Literature DB >> 29464182 |
Hua Yang1, Jian Gao2,3, Limin Ren1, Shuyu Li1, Zhangyan Chen1, Junfang Huang4, Shanzhu Zhu1, Zhigang Pan1.
Abstract
Knowledge-attitude-practices (KAP) significantly impact the outcome of self-management in patients with diabetes, yet the association between KAP and the combined control of the levels of blood glucose, blood pressure, and blood lipids in these patients remains uncertain. This community-based cross-sectional study was conducted from December 2014 to December 2016 on 3977 patients with type 2 diabetes in Shanghai. KAP were evaluated using the modified Chinese version of the Diabetes, Hypertension and Hyperlipidemia (DHL) Knowledge Instrument, Diabetes Empowerment Scale-Short Form (DES-SF), and Summary of Diabetes Self-Care Activities (SDSCA). Clinical and biochemical measurements were performed at each sampling site. The association between KAP scores and achieving the combined target goal was assessed by multiple logistic regression. Patients having a higher score of knowledge were more likely to achieve the combined target goal. Furthermore, a turning point of knowledge score was found that the possibility of achieving the combined target goal presented a sharp increase when the knowledge score was more than 70. However, the scores of attitude and practices had no significant relations with achieving the combined target goal. Health intervention strategies, especially increasing integrated diabetes knowledge, should be targeted to patients with type 2 diabetes in communities.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29464182 PMCID: PMC5804409 DOI: 10.1155/2017/3901392
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Figure 1Inclusion/exclusion criteria for the current study participants for the assessment of the association between KAP and achieving combined target goal.
Prevalence of achieving the combined target goal in patients with T2DM by sociodemographic and clinical characteristics.
| Variables | Total | Achieving the combined target goal | Not achieving the combined target goal |
|
|
|---|---|---|---|---|---|
| Age (year), mean ± SD | 67.4 ± 8.4 | 68.9 ± 7.4 | 67.3 ± 8.4 | 1.330 | 0.184∗ |
| Gender, | |||||
| Male | 808 | 36 (4.5) | 772 (95.5) | 12.107 | 0.001# |
| Female | 1089 | 19 (1.7) | 1070 (98.3) | ||
| Educational attainment, | |||||
| Elementary or lower | 692 | 8 (1.2) | 684 (98.8) | 14.671 | 0.002# |
| Junior high school | 781 | 26 (3.3) | 755 (96.7) | ||
| High school | 262 | 12 (4.6) | 250 (95.4) | ||
| College | 162 | 9 (5.6) | 153 (94.4) | ||
| Marital status, | |||||
| Single, divorced, or windowed | 106 | 3 (2.8) | 103 (97.2) | 0.000 | 1.000# |
| Married or cohabitating | 1791 | 52 (2.9) | 1739 (97.1) | ||
| Smoking status, | |||||
| Previous smoker/never smoked | 1524 | 44 (2.9) | 1480 (97.1) | 0.004 | 0.949# |
| Current smoker | 373 | 11 (2.9) | 362 (97.1) | ||
| Family history of diabetes mellitus, | |||||
| No | 1274 | 29 (2.3) | 1245 (97.7) | 6.967 | 0.008# |
| Yes | 522 | 24 (4.6) | 498 (95.4) | ||
| Duration of diabetes mellitus (year), mean ± SD | 9.2 ± 6.0 | 9.3 ± 6.5 | 9.2 ± 6.0 | 0.157 | 0.876∗ |
| Onset age (year), mean ± SD | 58.3 ± 9.1 | 59.7 ± 8.5 | 58.2 ± 9.1 | 1.129 | 0.259 |
| Current medical treatment, | |||||
| Without medicine | 137 | 3 (2.2) | 134 (97.8) | 0.731# | |
| Oral medicine | 1375 | 38 (2.8) | 1337 (97.2) | 1.293 | |
| Insulin | 150 | 6 (4.0) | 144 (96.0) | ||
| Oral medicine + insulin | 135 | 5 (3.7) | 130 (96.3) | ||
| Hypertension, | |||||
| No | 474 | 21 (4.4) | 453 (95.6) | 5.262 | 0.022# |
| Yes | 1423 | 34 (2.4) | 1389 (97.6) | ||
| CAD, | |||||
| No | 1728 | 52 (3.0) | 1676 (97.0) | 0.452 | 0.501# |
| Yes | 169 | 3 (1.8) | 166 (98.2) | ||
| Stroke, | |||||
| No | 1767 | 50 (2.8) | 1717 (97.2) | 0.505 | 0.444# |
| Yes | 130 | 5 (3.8) | 125 (96.2) | ||
| BMI (kg/m2), | |||||
| <18.5 | 18 | 1 (5.6) | 17 (94.4) | 0.001# | |
| ≥18.5, <24 | 599 | 30 (5.0) | 569 (95.0) | 15.187 | |
| ≥24 | 1260 | 23 (1.8) | 1237 (98.2) | ||
| SP, mean ± SD | 135.5 ± 15.5 | 122.2 ± 10.3 | 135.9 ± 15.5 | −9.544 | <0.001∗ |
| DP, mean ± SD | 79.6 ± 8.4 | 72.5 ± 4.6 | 79.8 ± 8.4 | −11.238 | <0.001∗ |
| HbA1c (%), mean ± SD | 7.3 ± 1.5 | 6.2 ± 0.4 | 7.3 ± 1.5 | −16.932 | <0.001∗ |
| TC (mmol/L), mean ± SD | 4.8 ± 1.0 | 3.8 ± 0.5 | 4.9 ± 1.0 | −14.953 | <0.001∗ |
| TG (mmol/L), mean ± SD | 1.6 ± 1.2 | 0.9 ± 0.3 | 1.7 ± 1.2 | −15.222 | <0.001∗ |
| LDL-C (mmol/L), mean ± SD | 2.8 ± 0.9 | 1.9 ± 0.5 | 2.8 ± 0.9 | −12.773 | <0.001∗ |
| HDL-C (mmol/L), mean ± SD | 1.4 ± 0.4 | 1.5 ± 0.3 | 1.4 ± 0.4 | 2.830 | 0.005∗ |
| BUN (mmol/L), mean ± SD | 5.6 ± 1.7 | 5.5 ± 1.3 | 5.6 ± 1.7 | −0.650 | 0.516∗ |
| SCr (umol/L), mean ± SD | 68.6 ± 24.6 | 70.3 ± 19.9 | 68.5 ± 24.7 | 0.516 | 0.606∗ |
| UA (umol/L), mean ± SD | 307.9 ± 76.3 | 298.7 ± 69.2 | 308.1 ± 76.5 | −0.881 | 0.379∗ |
| eGFRa (mL·min−1 · (1.73 m2)−1), mean ± SD | 97.7 ± 28.5 | 101.1 ± 30.3 | 97.6 ± 28.5 | 0.872 | 0.383∗ |
| UACRb (mg/g), | |||||
| <30 | 1194 | 43 (3.6) | 1151 (94.4) | 0.011# | |
| 30–300 | 418 | 4 (1.0) | 414 (99.0) | 8.646 | |
| >300 | 58 | 1 (1.7) | 57 (98.3) | ||
| DRc, | |||||
| No | 515 | 12 (2.3) | 503 (97.7) | 0.455 | 0.500# |
| Yes | 119 | 1 (0.8) | 118 (99.2) |
BMI: body mass index; CAD: coronary heart disease; DR: diabetic retinopathy; eGFR: estimated glomerular filtration rate; UACR: urinary albumin creatinine ratio. aeGFR was calculated from the Modification of Diet in Renal Disease formula, as follows: eGFR (mL·min−1 · (1.73 m2)−1) = 186 × CRE (mg/dL)−1.154 × age−0.203 (× 0.742, if female). bUACR was measured on a single random urine sample and calculated from urinary albumin–creatinine ratio. cDR was defined on the international Clinical Grading Standards of Diabetic Retinopathy (2002) by the ophthalmologist according to the retinal photographs. The results were categorized into two levels: with DR or without DR. §The number of respondents included in the study. △Comparing participants under the combined control of blood glucose, blood pressure, and blood lipids with those out of combined control. ∗Using the t-test. Using chi-square test.
KAP scores of patients with T2DM who achieved or did not achieve the combined target goals.
| Variables | Total | Achieving the combined target goal | Not achieving the combined target goal |
|
| |
|---|---|---|---|---|---|---|
| Knowledge | Diabetes | 76.3 ± 23.9 | 88.4 ± 17.9 | 75.9 ± 23.9 | 5.022 | <0.001 |
| Hypertension | 72.5 ± 30.6 | 80.6 ± 27.7 | 72.2 ± 30.7 | 1.999 | 0.046 | |
| Hyperlipidemia | 39.5 ± 31.1 | 55.3 ± 30.8 | 39.0 ± 31.0 | 3.831 | <0.001 | |
| Medication | 74.7 ± 26.1 | 86.5 ± 17.3 | 74.3 ± 26.2 | 5.058 | <0.001 | |
| Total score | 65.9 ± 20.0 | 78.3 ± 15.3 | 65.6 ± 20.0 | 5.986 | <0.001 | |
| Attitude | 3.7 ± 0.8 | 3.8 ± 0.7 | 3.7 ± 0.8 | 0.722 | 0.471 | |
| Practices | General diet | 82.3 ± 27.3 | 84.4 ± 30.2 | 82.3 ± 27.2 | 0.573 | 0.567 |
| Specific diet | 48.8 ± 24.4 | 47.9 ± 27.6 | 48.8 ± 24.3 | −0.262 | 0.793 | |
| Exercise | 40.1 ± 25.1 | 45.5 ± 22.7 | 40.0 ± 25.1 | 1.766 | 0.083 | |
| Blood glucose testing | 14.0 ± 20.8 | 15.5 ± 24.9 | 14.0 ± 20.7 | 0.524 | 0.600 | |
| Foot care | 36.1 ± 40.4 | 46.0 ± 43.8 | 35.8 ± 40.3 | 1.831 | 0.067 | |
| Medications | 81.3 ± 36.8 | 87.8 ± 29.7 | 81.1 ± 37.0 | 1.639 | 0.106 | |
| Total score | 47.6 ± 14.3 | 51.5 ± 14.6 | 47.5 ± 14.3 | 2.019 | 0.044 | |
△Comparing participants under the combined control of blood glucose, blood pressure, and blood lipids with those out of combined control.
Association between KAP scores and achieving the combined target goal.
| Independent variables | Unadjusted | Model 1 | Model 2 |
|---|---|---|---|
| Knowledge score | |||
| Quartile 1 | 1 | 1 | 1 |
| Quartile 2 | 1.126 (0.341–3.717) | 1.151 (0.348–3.807) | 1.336 (0.330–5.405) |
| Quartile 3 | 2.964 (1.159–7.577) | 2.849 (1.112–7.297) | 3.803 (1.251–11.562) |
| Quartile 4 | 5.448 (2.229–13.316) | 5.238 (2.139–12.838) | 6.519 (2.196–19.347) |
| | <0.001 | <0.001 | <0.001 |
| Attitude score | |||
| Quartile 1 | 1 | 1 | 1 |
| Quartile 2 | 1.512 (0.685–3.336) | 1.547 (0.699–3.421) | 1.681 (1.733–3.851) |
| Quartile 3 | 1.445 (0.635–3.287) | 1.474 (0.646–3.364) | 1.299 (0.535–3.154) |
| Quartile 4 | 1.413 (0.621–3.213) | 1.371 (0.601–3.128) | 1.257(0.529–2.987) |
| | 0.492 | 0.545 | 0.859 |
| Practice score | |||
| Quartile 1 | 1 | 1 | 1 |
| Quartile 2 | 1.736 (0.772–3.905) | 1.675 (0.743–3.778) | 1.642 (0.697–3.866) |
| Quartile 3 | 1.067 (0.449–2.535) | 1.021 (0.429–2.431) | 1.008 (0.409–2.485) |
| Quartile 4 | 2.123 (0.976–4.615) | 2.030 (0.931–4.427) | 1.778 (0.775–4.080) |
| | 0.137 | 0.171 | 0.332 |
Dependent variable: achieving or not achieving the combined target goal. Model 1: adjusted for age and gender. Model 2: adjusted for age, gender, educational attainment, marital status, family history of diabetes mellitus, duration of diabetes mellitus, current medical treatment, and smoking status.
Figure 2Curve fitting between knowledge score and ln(OR). OR for achieving combined target goal associated with an increase in knowledge score. Adjusted for age, gender, educational attainment, marital status, family history of diabetes mellitus, duration of diabetes mellitus, current medical treatment, and smoking status. The dotted line presented 95%CI.